<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> is a B cell <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> prone to transformation into a large cell diffuse histology </plain></SENT>
<SENT sid="1" pm="."><plain>This progression may be multi-clonal as determined by IgH rearrangement </plain></SENT>
<SENT sid="2" pm="."><plain>Similar multi-clonal occurrences have been described in immunocompromised patients </plain></SENT>
<SENT sid="3" pm="."><plain>However, the <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cells remain predominantly of B cell type </plain></SENT>
<SENT sid="4" pm="."><plain>Rarely, composite <z:hpo ids='HP_0002665'>lymphomas</z:hpo> with diffuse T cell histology have been reported arising from follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>The development of T cell <z:mpath ids='MPATH_336'>leukaemia</z:mpath> in a patient with a pre-existing B cell <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> is an extremely rare event </plain></SENT>
<SENT sid="6" pm="."><plain>The occurrence of T cell <z:hpo ids='HP_0011009'>acute</z:hpo> lymphoblastic <z:mpath ids='MPATH_336'>leukaemia</z:mpath> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">T-ALL</z:e>) following follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (FL) has not previously been reported </plain></SENT>
<SENT sid="7" pm="."><plain>We report a case of Philadelphia positive (Ph+) T cell ALL developing in a patient who previously had FL which may give some insight into the cell of origin and the defects responsible for <z:e sem="disease" ids="C1608408" disease_type="Neoplastic Process" abbrv="">malignant transformation</z:e> of the lymphocytes </plain></SENT>
</text></document>